期刊名：Therapeutics

期刊主页：https://www.mdpi.com/journal/therapeutics

Therapeutics (ISSN 2813-9909) 是一个国际同行评审的开放获取学术期刊。本刊致力于发表人类疾病预防与治疗领域的前沿研究，涵盖现代及传统成熟治疗技术。本刊刊载综述、原创研究、指南、通讯等类型，并鼓励学者尽可能详细地发表其实验和理论成果，包括可能被视为“负面”的结果。

1. Artificial Intelligence and Precision Pharmacotherapy in Pediatrics: A New Paradigm in Therapeutic Decision-Making

《人工智能与儿科精准药物治疗：治疗决策的新范式》

https://www.mdpi.com/2813-9909/3/1/6

Mondillo, G.; Perrotta, A.; Masino, M.; Colosimo, S.; Frattolillo, V.; Abbate, F.G. Artificial Intelligence and Precision Pharmacotherapy in Pediatrics: A New Paradigm in Therapeutic Decision-Making. Therapeutics 2026, 3, 6. https://doi.org/10.3390/therapeutics3010006

2. HIV-Associated Cryptococcal Meningitis: A Call for Action for New Treatment Options

《HIV相关隐球菌性脑膜炎：呼吁采取行动开发新的治疗方案》

https://www.mdpi.com/2813-9909/3/2/9

Okurut, S.; Meya, D.B. HIV-Associated Cryptococcal Meningitis: A Call for Action for New Treatment Options. Therapeutics 2026, 3, 9. https://doi.org/10.3390/therapeutics3020009

3. Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy

《含信号肽、CUB 域和 EGF 样结构域蛋白3（SCUBE3）：从分子到治疗》

https://www.mdpi.com/2813-9909/3/1/5

Ilesanmi, A.; Stevens-Washington, C.; Jones, S.; Alarcon, K.; Aryal, A.; Subbarayalu, P.; Shackleford, T.J.; Crossley, D.; Onyeagucha, B.C. Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy. Therapeutics 2026, 3, 5. https://doi.org/10.3390/therapeutics3010005

4. Lipoprotein(a) in Cardiovascular Disease: What Clinicians Need to Know: A Narrative Review

《心血管疾病中的脂蛋白(a)：临床医生需要了解的内容：一项叙事综述》

https://www.mdpi.com/2813-9909/3/2/11

Ricottini, E.; Ciavaroli, N.G.; Di Cristo, A.; Lentini, A.E.; Trunfio, T.; D’Antonio, L.; Mangiacapra, F.; Nusca, A.; Cammalleri, V.; Melfi, R.; et al. Lipoprotein(a) in Cardiovascular Disease: What Clinicians Need to Know: A Narrative Review. Therapeutics 2026, 3, 11. https://doi.org/10.3390/therapeutics3020011

5. Galectin-3 (Gal-3) Inhibitors as Radiosensitizers for Prostate Cancer

《半乳凝素-3（Gal-3）抑制剂作为前列腺癌的放射增敏剂》

https://www.mdpi.com/2813-9909/3/1/7

Rodrigues, R.M.; Matos, B.; Miranda-Gonçalves, V.; Jerónimo, C.; Fardilha, M. Galectin-3 (Gal-3) Inhibitors as Radiosensitizers for Prostate Cancer. Therapeutics 2026, 3, 7. https://doi.org/10.3390/therapeutics3010007

6. A Comparative Study of the Use of Half-Dose (7.5 MG) Versus Full-Dose (15 MG) of Tolvaptan in the Treatment of Hyponatremia Caused by the Syndrome of Inappropriate Antidiuresis (SIAD)

《半剂量（7.5毫克）与全剂量（15毫克）托伐普坦治疗因不适当抗利尿综合征（SIAD）引起的低钠血症的比较研究》

https://www.mdpi.com/2813-9909/3/1/4

Bassi, V.; Apuzzi, V.; Salzano, C.; Fattoruso, O. A Comparative Study of the Use of Half-Dose (7.5 MG) Versus Full-Dose (15 MG) of Tolvaptan in the Treatment of Hyponatremia Caused by the Syndrome of Inappropriate Antidiuresis (SIAD). Therapeutics 2026, 3, 4. https://doi.org/10.3390/therapeutics3010004

7. Multimodal Management of Spinal Cord Hemangioblastomas: A Comprehensive Review

《脊髓血管母细胞瘤的多模式管理：综述》

https://www.mdpi.com/2813-9909/3/2/12

Call-Orellana, F.A.; Zuluaga-Garcia, J.P.; Sierra, M.A.; Zuluaga-Garcia, M.; Ramirez-Ferrer, E.; Bugarini, A. Multimodal Management of Spinal Cord Hemangioblastomas: A Comprehensive Review. Therapeutics 2026, 3, 12. https://doi.org/10.3390/therapeutics3020012

8. The Use of Human Placental Allografts for Pyoderma Gangrenosum

《人类胎盘异体移植用于脓皮病》

https://www.mdpi.com/2813-9909/3/1/8

Chin, N.; Kallarackal, J.; Shenouda, J.; Pan, A.; Correa-Selm, L. The Use of Human Placental Allografts for Pyoderma Gangrenosum. Therapeutics 2026, 3, 8. https://doi.org/10.3390/therapeutics3010008

9. Effectiveness of Physical Activity and Lifestyle Interventions in Pediatric Populations at Cardiovascular Risk: A Systematic Review and Meta-Analysis

《心血管风险儿童群体中体育活动与生活方式干预的有效性：一项系统综述与荟萃分析》

https://www.mdpi.com/2813-9909/3/2/10

Contreras Zapata, K.E.; Cruz Hidalgo, N.X.; Villalobos González, N.C.; Rubio-Zarapuz, A.; Clemente-Suárez, V.J.; Martín Pérez, I.M.; Martín Pérez, S.E. Effectiveness of Physical Activity and Lifestyle Interventions in Pediatric Populations at Cardiovascular Risk: A Systematic Review and Meta-Analysis. Therapeutics 2026, 3, 10. https://doi.org/10.3390/therapeutics3020010

本刊所有文章均以开放获取形式出版，一经发表即可供全球读者免费并无限制地阅读。我们致力于通过高效的同行评审与快速的出版流程，确保您的重要研究成果能以最快速度产生广泛影响力。我们期待您的投稿，如有疑问，敬请联络编辑部 (therapeutics@mdpi.com)。